Cannabinoids.

Grotenhermen Franjo
Current Drug Targets-CNS & Neurological Disorders, 2005

Abstract

Since the discovery of an endogenous cannabinoid system, research into the pharmacology and therapeutic potential of cannabinoids has steadily increased. Two subtypes of G-protein coupled cannabinoid receptors, CB(1) and CB(1), have been cloned and several putative endogenous ligands (endocannabinoids) have been detected during the past 15 years. The main endocannabinoids are arachidonoyl ethanolamide (anandamide) and 2-arachidonoyl glycerol (2-AG), derivatives of arachidonic acid, that are produced "on demand" by cleavage of membrane lipid precursors. Besides phytocannabinoids of the cannabis plant, modulators of the cannabinoid system comprise synthetic agonists and antagonists at the CB receptors and inhibitors of endocannabinoid degradation. Cannabinoid receptors are distributed in the central nervous system and many peripheral tissues, including immune system, reproductive and gastrointestinal tracts, sympathetic ganglia, endocrine glands, arteries, lung and heart. There is evidence for some non-receptor dependent mechanisms of cannabinoids and for endocannabinoid effects mediated by vanilloid receptors. Properties of CB receptor agonists that are of therapeutic interest include analgesia, muscle relaxation, immunosuppression, anti-inflammation, antiallergic effects, improvement of mood, stimulation of appetite, antiemesis, lowering of intraocular pressure, bronchodilation, neuroprotection and antineoplastic effects. The current main focus of clinical research is their efficacy in chronic pain and neurological disorders. CB receptor antagonists are under investigation for medical use in obesity and nicotine addiction. Additional potential was proposed for the treatment of alcohol and heroine dependency, schizophrenia, conditions with lowered blood pressure, Parkinson's disease and memory impairment in Alzheimer's disease.

PMID:16266285
DOI:10.2174/156800705774322111
Category:Hemp Products

The best supplements with Cannabinoid in Hemp Products category:

Articles similar to "Cannabinoids."

  • The significance of Cannabinoid for Hemp Products: The Therapeutic Potential of Cannabis and Cannabinoids. ( Cannabis-based medications have been a topic of intense study since the endogenous cannabinoid system was discovered two decades ago... There is now clear evidence that cannabinoids are useful for the treatment of various medical conditions.)
  • The role of Cannabinoid in Hemp Products: Cannabis-based medicines for chronic neuropathic pain in adults. ( This review is one of a series on drugs used to treat chronic neuropathic pain... The potential benefits of cannabis-based medicine (herbal cannabis, plant-derived or synthetic THC, THC/CBD oromucosal spray) in chronic neuropathic pain might be outweighed by their potential harms. The quality of evidence for pain relief outcomes reflects the exclusion of participants with a history of substance abuse and other significant comorbidities from the studies, together with their small sample sizes. )
  • The significance of Cannabinoid for Hemp Products: Cannabidiol, cannabinol and their combinations act as peripheral analgesics in a rat model of myofascial pain. (Objective: This study investigated whether local intramuscular injection of non-psychoactive cannabinoids, cannabidiol (CBD), cannabinol (CBN), cannabichromene (CBC) and their combinations can decrease nerve growth factor (NGF)-induced masticatory muscle sensitization in female rats... These results suggest that peripheral application of these non-psychoactive cannabinoids may provide analgesic relief for chronic muscle pain disorders such as temporomandibular disorders and fibromyalgia without central side effects. )

Previous article

Endocannabinoids, Exercise, Pain, and a Path to Health With Aging.

Next article

Pharmacology of Cannabinoids.